FDA 483 Citations for Batch Production Records Under 21 CFR 111.255 and 111.260

23 hours ago

5 min read

Every batch of dietary supplement needs a batch production record (BPR) that shows it was made according to the master manufacturing record. FDA cited BPR problems often on system-generated Form FDA 483s in fiscal year 2025:

"Your batch production record did not include all required information," 111.260, 103 times
"You did not prepare a batch production record every time you manufactured a batch of dietary supplement," 111.255(a), 27 times

That is 130 citations. The BPR is the evidence for each batch. If it is incomplete, the firm cannot show what went into the product, how it was made, or that quality control approved its release.

What the citations mean

Examples written after "Specifically" usually describe:

No BPR for some batches, especially small or rush batches
Component lot numbers not recorded, so traceability is lost
Actual weights not recorded, or recorded without a second-person check
Equipment and cleaning not identified
Yields not calculated, or out-of-range yields with no investigation
Label reconciliation missing
No documented quality control review before release
Entries made after the fact, or by people who did not do the work

What Part 111 requires

Preparing the BPR (111.255). You must prepare a batch production record every time you manufacture a batch of a dietary supplement. The BPR must include complete information relating to the production and control of each batch, must accurately follow the appropriate master manufacturing record, and you must perform each step in the production of the batch.

Contents (111.260). The BPR must include, among other things:

The batch, lot or control number of the finished batch and of each lot of packaged and labeled supplement
The identity of equipment and processing lines used
The date and time of maintenance, cleaning and sanitizing of the equipment and processing lines, or a cross-reference to records where this is kept
The unique identifier assigned to each component, packaging and label lot used
The identity and weight or measure of each component used
A statement of the actual yield and a statement of the percentage of theoretical yield at appropriate phases of processing
The actual results obtained during any monitoring operation
The results of any testing or examination performed during the batch, or a cross-reference
Documentation that the finished supplement meets specifications
Documentation, at the time of performance, of the manufacture of the batch, including the date, the identity of the people performing each step, and the initials of the people verifying the weight or measure of each component and the addition of components
Documentation, at the time of performance, of packaging and labeling operations, including label reconciliation
Documentation, at the time of performance, that quality control personnel reviewed the BPR and approved or rejected any reprocessing, and approved and released, or rejected, the batch for distribution
Documentation of any material review and disposition decision, and of any reprocessing

How to respond to the 483

Part 111 does not set a deadline for responding, but most firms respond in writing within 15 business days of the close of the inspection, so FDA has the response before it decides on further action.

Assess the batches cited

For batches with missing records, gather what evidence exists, such as component usage, equipment logs and test results, and test reserve samples. Decide whether each batch can be shown to meet specifications. Where it cannot, assess product in distribution and whether a recall is needed.

Redesign the BPR

Generate the BPR from the approved MMR, with a field for every element of 111.260. Include second-person verification of weights and additions, yield calculations with limits, and a label reconciliation section.

Require quality control review before release

Make quality control review of the complete BPR a documented step before release, and block shipment until it is done.

Apply good documentation practices

Entries must be made at the time of performance by the person who did the work. Corrections must be single-line, initialed, dated and explained. Blank fields must be addressed.

Train and verify

Train production and quality control staff, and audit completed BPRs for several months.

What a compliant BPR procedure contains

BPR generated from the current MMR
Every element required by 111.260
Second-person verification of weights and additions
Yield calculations and deviation investigation
Packaging and labeling records and label reconciliation
Quality control review and release
Documentation practices
Retention for at least 1 year past the shelf life date, or 2 years beyond distribution of the last batch if there is no shelf life date, as required by 111.605

Common mistakes in BPR responses

Recreating missing records after the fact
Adding fields without training people to complete them
Leaving release possible before quality control review
Ignoring yield deviations because product "looked fine"
Forgetting packaging and labeling documentation

Example: how one response section might read

This illustrates structure only; your response must describe your own products and facts.

Observation 6: Your batch production record did not include all required information. Specifically, the BPR for batch 25-0412 does not record component lot numbers, second-person verification of weights or quality control release.

Response:

Product assessment: Component usage was reconstructed from inventory transactions, and reserve samples were tested against finished product specifications on a stated date. All results met specifications.
Extended review: BPRs for all batches released in the last year were reviewed. Twenty-two had missing elements, each assessed with the same approach.
Corrective action: A new BPR form generated from the MMR includes every 111.260 element. Quality control release is now required in the inventory system before shipment.
Training: Production and quality control staff were trained on the form and documentation practices.
Verification: Quality control will audit 10 completed BPRs per month for six months.

Frequently asked questions

Does every batch need a BPR, even small pilot batches sold to customers?

Yes. Every batch of dietary supplement manufactured for distribution needs a BPR under 111.255.

Can the BPR be electronic?

Yes, if it captures all required information. Electronic records are also subject to 21 CFR Part 11 where it applies, under 111.610.

How long must BPRs be kept?

At least 1 year past the shelf life date, if shelf life dating is used, or 2 years beyond the date of distribution of the last batch associated with the records, under 111.605.

How A.P. Lyon documents help

A.P. Lyon's Dietary Supplement cGMP Quality System (21 CFR 111) includes a batch production record procedure and form built on 111.260, with label reconciliation and quality control release. Brand owners can use the Supplement Brand Owner Compliance Pack to review contract manufacturers' batch records before release.

Documents are editable Word and Excel files and must be adapted to your products and operations. Your staff must be trained and the procedures followed.

Next steps

Assess each cited batch with available evidence and reserve samples
Generate BPRs from the MMR with every required element
Require quality control review before release
Respond in writing within 15 business days with dates for each action

To compare the complete system with the brand owner pack, see all dietary supplement documents.

Not sure where your quality system stands? Take the free QMS gap check: about 20 questions, an instant report of your gaps by clause, and the procedures that close each one.